Astrivax
4 known investors
Astrivax Therapeutics is a clinical-stage biopharmaceutical company developing immunotherapies to treat virus-driven cancers, particularly HPV16-associated cancers like cervical and head and neck cancer. The company's Launch-iT platform generates durable T-cell responses against virus-infected cells and is advancing toward clinical proof-of-concept.
Investors · 4
Frequently asked questions
- What does Astrivax do?
- Astrivax Therapeutics is a clinical-stage biopharmaceutical company developing immunotherapies to treat virus-driven cancers, particularly HPV16-associated cancers like cervical and head and neck cancer. The company's Launch-iT platform generates durable T-cell responses against virus-infected cells and is advancing toward clinical proof-of-concept.
- Who are Astrivax's investors?
- Astrivax's investors include Fund+, Korys, PMV, V-Bio Ventures.